https://www.selleckchem.com/pr....oducts/iclepertin.ht
BACKGROUND Breast cancer incidence rates have been continuously increasing in majority nations with significant higher portion of cancer-related mortality in low- and middle-income countries. Developing new biomarker is an emerging field in the breast cancer research. Application of a promising minimally invasive biomarker, circulating microRNA, for additional improvement of diagnosis, prognosis, and therapeutic monitoring in breast cancer is not well corroborated. MATERIALS AND METHODS To uncover the potential use of circulating miR
Curtir
Comentario
Compartilhar
